Scott M. Norberg, D.O.

Dr. Norberg researches the use of immunotherapy and cellular therapy for a variety of conditions including human papillomavirus-positive (HPV+) cancers and premalignant diseases caused by chronic HPV infection. His research focuses on understanding resistance to immunotherapy and cellular therapies and applying these treatment modalities to other conditions.
1) cell therapy, 2) immunotherapy, 3) human papillomavirus, 4) cervical cancer, 5) oropharyngeal cancer, 6) anal cancer
Contact Info
Center for Cancer Research
National Cancer Institute
Building 10, Room 6B09
Bethesda, MD 20892
Ph: 240-858-3303
scott.norberg@nih.gov
-
A Phase I Study of Adjuvant PRGN-2012 in Adult Patients with Recurrent Respiratory Papillomatosis
Open - Not yet RecruitingNCI Protocol ID NCI-21-C-0013Investigator Scott M. Norberg, D.O. -
A Phase II Study of E7 TCR T Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer
Open - RecruitingNCI Protocol ID NCI-19-C-0122Investigator Scott M. Norberg, D.O. -
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers
Open - RecruitingNCI Protocol ID NCI-16-C-0154Investigator Scott M. Norberg, D.O. -
Collection of Peripheral Blood Mononuclear Cells (PBMCs) from Healthy Subjects for the Expansion of T Cells for Adoptive Cell Therapy
Open - RecruitingNCI Protocol ID NCI-16-C-0138Investigator Scott M. Norberg, D.O. -
Biospecimen Procurement for Genitourinary Malignancies and Experimental Transplantation and Immunology Branch Immunotherapy Protocols
Open - RecruitingNCI Protocol ID NCI-16-C-0061Investigator Scott M. Norberg, D.O.
Dr. Norberg conducts clinical research to develop T cell therapies for the treatment of patients with cancer and precancerous diseases. This includes conducting clinical trials using genetically engineered T cells to treat patients with advanced human papillomavirus (HPV) malignancies.
Selected Recent Publications
- Nat Med. 2021. Full-Text Article [ Journal Article ]
- J Immunother Cancer. 7(1): 229, 2019. [ Journal Article ]
- J Immunother Cancer. 7(1): 119, 2019. [ Journal Article ]
Dr. Norberg received his B.S. from Saint Mary’s College of California and a M.S. in Medical Sciences at Drexel University. He received his medical degree at the Philadelphia College of Osteopathic Medicine. He completed his residency in internal medicine at Temple University Hospital and a fellowship in medical oncology at the National Cancer Institute. After fellowship training, he joined the research group of Dr. Christian Hinrichs where he conducts clinical research to develop T-cell therapies for patients with malignant and premalignant disease.
Dr. Norberg is board certified in internal medicine and medical oncology.
Name | Position |
---|---|
Megan Kenyon PA-C | Physician Assistant |